Micheliolide provides protection of mice against Staphylococcus aureus and MRSA infection by down-regulating inflammatory response

A major obstacle to therapy in intensive care units is sepsis caused by severe infection. In recent years gram-positive (G(+)) bacteria, most commonly staphylococci, are thought to be the main pathogens. Micheliolide (MCL) was demonstrated to provide a therapeutic role in rheumatoid arthritis, infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xinru, Wang, Yuli, Qin, Yifei, He, Weigang, Benlahrech, Adel, Zhang, Qingwen, Jiang, Xin, Lu, Zhenhui, Ji, Guang, Zheng, Yuejuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292736/
https://www.ncbi.nlm.nih.gov/pubmed/28165033
http://dx.doi.org/10.1038/srep41964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292736/
https://www.ncbi.nlm.nih.gov/pubmed/28165033
http://dx.doi.org/10.1038/srep41964

Ejemplares similares